GenVec's new CEO, Cynthia Collins, will restructure the company, eliminating about a third of its workforce. Collins, who joined GenVec in the spring, announced she will slash 23 jobs throughout the organization. She said cuts are necessary "to ensure that our costs are more closely aligned with our resources and business strategy." Release | FierceBiotech story